Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020-US

  • ID: 3774298
  • Drug Pipelines
  • 60 pages
  • DelveInsight
1 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Baxter Oncology
  • Medison Pharma
  • Merck KGaA
  • Merck KGaA
  • Novartis Pharmaceuticals
  • MORE
“Ovarian Cancer - Market Insights, Epidemiology and Market Forecast-2020- US” Reports provides an overview of the disease and global market size of the Ovarian Cancer for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Ovarian Cancer from 2012-2020. According to the publisher, the forecasted patient population of Ovarian cancer will decrease at a CAGR of 0.54% from 2012 to 2020 and the worldwide Ovarian cancer market is estimated to be 921.2 million by 2020. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Note: This report will be delivered to the client in 48 hours

Scope
- Report covers the disease overview, current treatment options, prescription drugs and emerging therapies.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States from 2012-2020.
- It also provides Market size of Ovarian Cancer for United States and forecasted Market size to 2020
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AbbVie Inc.
  • Baxter Oncology
  • Medison Pharma
  • Merck KGaA
  • Merck KGaA
  • Novartis Pharmaceuticals
  • MORE
Table of Contents

1 Report Introduction
2 Executive Summary
- Key Findings
3 Ovarian Cancer Market Overview at a Glance
4 Treatment Landscape
- Treatment Options by Stage
- Stage IA
- Stage IB
- Stage IC
- Stage IIA
- Stage IIB, Stage IIC, Stage IIIA, Stage, IIIB, Stage IIIC, Stage IV
- Treatment Algorithm
- Treatment Follow-Up
5 Epidemiology and Patient Population
- Key Findings
- Overview
- Disease Classification
- Population and Forecast Methodology
- Total Incident Cases
- Diagnosed Drug Treated Population
- Percentage Diagnosed
- Percentage Drug Treated
6 Current Medical Practice and Therapies in Use
- Key Findings
- Overview of Ovarian Cancer
- Treatment Goals
- Currently Medical Practice
- Overview of Ovarian Cancer Drug Classification
- Prescription Drugs, Dosing & Route
- Targeted Therapies & Adverse Events
7 Emerging Therapies
- Key Findings
- Unmet need
- Late Stage Pipeline Overview
- Expected Launch date of these therapies in United States
- Late Stage Pipeline Analysis
8 United States Market Assessment
- Key Findings
- United States Market Forecast
- United States Market Size
- Market Driver and Constraints
- Factors Driving the Market for ER+ Ovarian Cancer
- Factors Constraining the Market for ER+ Ovarian Cancer
9 Consulting Services
10 Disclaimer
11 About us
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- AbbVie Inc.
- Oasmia Pharmaceutical AB
- Merck KGaA
- Novartis Pharmaceuticals
- Baxter Oncology
- Medison Pharma
- Orion Pharmaceuticals
- Merck KGaA
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll